These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 28377940)

  • 1. Dimethyl fumarate-induced lymphopenia in MS due to differential T-cell subset apoptosis.
    Ghadiri M; Rezk A; Li R; Evans A; Luessi F; Zipp F; Giacomini PS; Antel J; Bar-Or A
    Neurol Neuroimmunol Neuroinflamm; 2017 May; 4(3):e340. PubMed ID: 28377940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment response to dimethyl fumarate is characterized by disproportionate CD8+ T cell reduction in MS.
    Fleischer V; Friedrich M; Rezk A; Bühler U; Witsch E; Uphaus T; Bittner S; Groppa S; Tackenberg B; Bar-Or A; Zipp F; Luessi F
    Mult Scler; 2018 Apr; 24(5):632-641. PubMed ID: 28436295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dimethyl fumarate induced lymphopenia in multiple sclerosis: A review of the literature.
    Dello Russo C; Scott KA; Pirmohamed M
    Pharmacol Ther; 2021 Mar; 219():107710. PubMed ID: 33091427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dimethyl fumarate selectively reduces memory T cells in multiple sclerosis patients.
    Longbrake EE; Ramsbottom MJ; Cantoni C; Ghezzi L; Cross AH; Piccio L
    Mult Scler; 2016 Jul; 22(8):1061-1070. PubMed ID: 26459150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction of CD8(+) T lymphocytes in multiple sclerosis patients treated with dimethyl fumarate.
    Spencer CM; Crabtree-Hartman EC; Lehmann-Horn K; Cree BA; Zamvil SS
    Neurol Neuroimmunol Neuroinflamm; 2015 Jun; 2(3):e76. PubMed ID: 25738172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dimethyl fumarate treatment alters circulating T helper cell subsets in multiple sclerosis.
    Gross CC; Schulte-Mecklenbeck A; Klinsing S; Posevitz-Fejfár A; Wiendl H; Klotz L
    Neurol Neuroimmunol Neuroinflamm; 2016 Feb; 3(1):e183. PubMed ID: 26767188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dimethyl Fumarate Treatment Mediates an Anti-Inflammatory Shift in B Cell Subsets of Patients with Multiple Sclerosis.
    Li R; Rezk A; Ghadiri M; Luessi F; Zipp F; Li H; Giacomini PS; Antel J; Bar-Or A
    J Immunol; 2017 Jan; 198(2):691-698. PubMed ID: 27974457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of dimethyl fumarate on lymphocyte subsets.
    Berkovich R; Weiner LP
    Mult Scler Relat Disord; 2015 Jul; 4(4):339-41. PubMed ID: 26195053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High CD4+:CD8+ ratios with herpes zoster infections in patients with multiple sclerosis on dimethyl fumarate.
    Balshi A; Saart E; Pandeya S; Dempsey J; Baber U; Sloane JA
    Mult Scler; 2023 Oct; 29(11-12):1465-1470. PubMed ID: 37572049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors associated with dimethyl fumarate-induced lymphopenia.
    Sainz de la Maza S; Medina S; Villarrubia N; Costa-Frossard L; Monreal E; Tejeda-Velarde A; Rodríguez-Martín E; Roldán E; Álvarez-Cermeño JC; Villar LM
    J Neurol Sci; 2019 Mar; 398():4-8. PubMed ID: 30658226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging Understanding of the Mechanism of Action for Dimethyl Fumarate in the Treatment of Multiple Sclerosis.
    Mills EA; Ogrodnik MA; Plave A; Mao-Draayer Y
    Front Neurol; 2018; 9():5. PubMed ID: 29410647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Varicella-Zoster Reactivation in a Non-immunized Elderly Multiple Sclerosis Patient While on Delayed-Release Dimethyl Fumarate With Grade 2 Lymphopenia and Profoundly Low CD4+ and CD8+ Cell Counts: A Case Report.
    Daripa B; Lucchese S
    Cureus; 2022 Feb; 14(2):e22679. PubMed ID: 35386173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A retrospective analysis of changes in lymphocyte levels in patients with multiple sclerosis during and after Tecfidera® treatment.
    Baeva ME; Baev PB; Nelson J; Kazimirchik A; Vorobeychik G
    Mult Scler J Exp Transl Clin; 2021; 7(3):20552173211029674. PubMed ID: 34345437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphocyte subtypes in relapsing-remitting multiple sclerosis patients treated with dimethyl fumarate.
    Chaves C; Ganguly R; Ceresia C; Camac A
    Mult Scler J Exp Transl Clin; 2017; 3(2):2055217317702933. PubMed ID: 28607757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of dimethyl fumarate on lymphocyte subsets in patients with relapsing multiple sclerosis.
    Buckle G; Bandari D; Greenstein J; Gudesblatt M; Khatri B; Kita M; Repovic P; Riser E; Weinstock-Guttman B; Thrower B; Loring S; Riester K; Everage N; Prada C; Koulinska I; Mann M
    Mult Scler J Exp Transl Clin; 2020; 6(2):2055217320918619. PubMed ID: 32440353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of lymphopenia in patients with MS treated with dimethyl fumarate and fingolimod.
    Nakhaei-Nejad M; Barilla D; Lee CH; Blevins G; Giuliani F
    Neurol Neuroimmunol Neuroinflamm; 2018 Mar; 5(2):e432. PubMed ID: 29296636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dimethyl fumarate-associated lymphopenia: Risk factors and clinical significance.
    Longbrake EE; Naismith RT; Parks BJ; Wu GF; Cross AH
    Mult Scler J Exp Transl Clin; 2015; 1():. PubMed ID: 26550483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Naïve and central memory T-cell lymphopenia in end-stage renal disease.
    Yoon JW; Gollapudi S; Pahl MV; Vaziri ND
    Kidney Int; 2006 Jul; 70(2):371-6. PubMed ID: 16738532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient outcomes influenced by reduced lymphocyte counts after dimethyl fumarate initiation.
    Wright K; Winkler MD; Newton BD; Sormani MP; Okuda DT
    Neurol Neuroimmunol Neuroinflamm; 2017 Nov; 4(6):e397. PubMed ID: 28959705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential sensitivity of naïve and subsets of memory CD4+ and CD8+ T cells to hydrogen peroxide-induced apoptosis.
    Gupta S; Young T; Yel L; Su H; Gollapudi S
    Genes Immun; 2007 Oct; 8(7):560-9. PubMed ID: 17690685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.